Roxadustat increases odds of vascular access thrombosis and all-cause mortality in patients with chronic kidney disease
Roxadustat Linked to Higher Risk of Blood Clots in Kidney Patients
This systematic review and meta-analysis of 11,418 adults with chronic kidney disease found that roxadustat is associated with higher odds o…
A review of over 11,000 patients suggests roxadustat may increase the risk of blood clots and death for those with chronic kidney disease.
Vitamin D improves strength and reduces injuries in dancers, while iron lowers anemia prevalence
Dancers take many supplements, but benefits are often unproven and risks remain unclear
This systematic review of dietary supplement and medication use in 654 female and 86 male professional and pre-professional dancers found vi…
Dancers use many supplements and painkillers, yet benefits are limited and potential health risks need more study before we can trust them.
Systematic review reveals high prevalence of sickle cell disease across infants and youth in sub-Saharan Africa
Sickle cell disease affects nearly 2 percent of kids under 15 in sub-Saharan Africa
A comprehensive meta-analysis of 40 studies from 22 nations highlights the burden of sickle cell disease in sub-Saharan Africa. Prevalence r…
New analysis shows sickle cell disease is more common than thought in infants and children across sub-Saharan Africa, highlighting a critica…
Systematic review and meta-analysis finds roxadustat improves hemoglobin in peritoneal dialysis patients
Roxadustat Boosts Hemoglobin in Peritoneal Dialysis Patients
This systematic review and meta-analysis of 607 patients receiving peritoneal dialysis found that roxadustat significantly increased hemoglo…
A review of 607 patients on peritoneal dialysis finds roxadustat raises hemoglobin and iron levels while lowering hepcidin.
Narrative review of CRISPR-Cas9 and Fanzor gene therapies for sickle cell disease
New CRISPR gene therapies for sickle cell disease face lingering technology limits
This narrative review synthesizes evidence on CRISPR-Cas9-based gene therapies and the Fanzor system for sickle cell disease. The authors no…
A review of CRISPR-Cas9 gene therapies for sickle cell disease notes that limitations in the technology still persist.
Systematic review and meta-analysis of liposomal iron versus conventional iron in pediatric iron deficiency anemia
Liposomal iron improves blood counts and reduces side effects in children with anemia
This systematic review and meta-analysis evaluated liposomal iron versus conventional oral iron in 454 children with iron deficiency anemia …
A meta-analysis found liposomal iron raised hemoglobin more and caused fewer side effects than conventional iron in children.
Systematic review examines early erythropoiesis-stimulating agents for preterm infants across multiple clinical outcomes and safety endpoints
Early blood boosters may lower severe brain injury risk in premature babies
A systematic review of 37 trials involving 6,724 preterm or low-birthweight infants found that early erythropoiesis-stimulating agents likel…
A review of 37 studies suggests early blood boosters might lower severe brain injury and severe gut illness in premature infants without rai…
Systematic review and meta-analysis of erythropoiesis-stimulating agents in chronic heart failure and anaemia
New drugs help heart failure patients stay out of the hospital
This systematic review and meta-analysis evaluated erythropoiesis-stimulating agents (ESAs) in adults with chronic heart failure and anaemia…
A new review shows specific drugs can keep heart failure patients out of the hospital while improving their daily energy and movement.
FDA Approves Epysqli (eculizumab-sbja) for PNH, aHUS, and gMG
FDA approves new drug Epysqli for three rare blood and nerve conditions.
The FDA approved Epysqli (eculizumab-sbja) for paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and gen…
The FDA approved Epysqli (eculizumab-sbja) for paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and generalized myas…
Eltrombopag addition alters clonal hematopoiesis dynamics in untreated severe aplastic anemia patients over 24 months
Adding Eltrombopag helps severe anemia patients recover blood counts significantly faster
This Phase 3 randomized trial reviewed patient samples from 170 untreated patients with severe or very severe aplastic anemia receiving eltr…
Adding Eltrombopag helps severe anemia patients recover blood counts faster without increasing cancer risks but genetic changes rise over ti…
Eltrombopag plus immunosuppression for severe aplastic anemia shows clonal evolution patterns
Treatment for severe anemia reveals two paths to cancer risk
This phase 2 observational study followed 204 patients with severe aplastic anemia treated with immunosuppression plus eltrombopag for a med…
New research tracks cancer risks in severe anemia patients treated with standard therapy over five years
Iron micronutrient powders reduce malaria-induced anaemia but not growth in young children
Iron powders reduce malaria-related anaemia in young children
This cluster-randomized trial in 1,806 Ghanaian children aged 6-35 months found that daily iron-containing micronutrient powders for five mo…
Daily iron-based micronutrient powders can lower the risk of malaria-induced anaemia in preschool children in Ghana.
Questions about Anemia
Does taking iron powders for five months help children with malaria-induced anaemia?
Taking iron powders for five months helps children with malaria-induced anaemia by raising haemoglobin levels, but it does not improve growth measurements like height or weight.
Full answer →Do erythropoiesis-stimulating agents help adults with heart failure and anaemia?
ESAs reduce total heart failure hospitalizations and improve hemoglobin and exercise tolerance, but do not lower first hospitalization or mortality risk.
Full answer →How common is anemia among pregnant women who participate in the WIC program?
Anemia among pregnant WIC participants increased from 10.1% in 2008 to 11.4% in 2018, with higher rates in Black women and later trimesters.
Full answer →All Anemia Articles
- Roxadustat increases odds of vascular access thrombosis and all-cause mortality in patients with chronic kidney disease
- Vitamin D improves strength and reduces injuries in dancers, while iron lowers anemia prevalence
- Systematic review reveals high prevalence of sickle cell disease across infants and youth in sub-Saharan Africa
- Systematic review and meta-analysis finds roxadustat improves hemoglobin in peritoneal dialysis patients
- Narrative review of CRISPR-Cas9 and Fanzor gene therapies for sickle cell disease
- Systematic review and meta-analysis of liposomal iron versus conventional iron in pediatric iron deficiency anemia
- Systematic review examines early erythropoiesis-stimulating agents for preterm infants across multiple clinical outcomes and safety endpoints
- Systematic review and meta-analysis of erythropoiesis-stimulating agents in chronic heart failure and anaemia
- FDA Approves Epysqli (eculizumab-sbja) for PNH, aHUS, and gMG
- Eltrombopag addition alters clonal hematopoiesis dynamics in untreated severe aplastic anemia patients over 24 months
- Eltrombopag plus immunosuppression for severe aplastic anemia shows clonal evolution patterns
- Iron micronutrient powders reduce malaria-induced anaemia but not growth in young children
- Pretreatment sTNFR1 and infection predict transplant-associated thrombotic microangiopathy in severe aplastic anemia
- Eltrombopag monotherapy assessed in moderate aplastic anemia and unilineage bone marrow failure disorders
- Systematic review and meta-analysis shows dapagliflozin increases hemoglobin in chronic kidney disease patients
- Cross-Sectional Analysis of Cardiac Structure and Function in 57 Adults With Sickle Cell Disease
- Scoping review identifies poor health outcomes in children under seven with care experience in high-income countries
- Hematocrit–albumin gap linked to sepsis risk in ICU adults in retrospective analysis
- Video capsule endoscopy in children shows diagnostic yield for Crohn's disease but requires endoscopic placement
- POCUS-guided assessments and serial exchange transfusions improved outcomes in a 20-year-old male with sickle cell disease and acute chest syndrome
- Total IgG Concentration Linked to Anemia in Hemodialysis Patients
- Renizgamglogene autotemcel infusion showed engraftment and hemoglobin increases in severe sickle cell disease patients
- Proteogenomic analysis in sickle cell disease identifies 560 pQTL and prioritizes five proteins for HbF investigation
- Delayed consultation and sickle cell disease associated with poor outcomes in pediatric osteomyelitis in Cameroon
- Point-of-care hemoglobin meters show high sensitivity but lower specificity versus analyzer in Ghanaian study
- U.S. newborn screening for alpha-thalassemia shows state-to-state variation in detection practices
- Sickle cell disease birth prevalence examined in newborns from high social vulnerability counties
- Report describes anemia prevalence among pregnant women participating in WIC program
- Systematic review finds first FDA-approved CRISPR therapy and broader clinical trial exploration
- Meta-analysis links lower Fe, Zn, Mg and higher Cu levels to iron deficiency anemia in children
- Report examines use of recommended health care measures for sickle cell anemia complications in youth
- L-arginine shows no significant benefit for pain or hospital outcomes in sickle cell disease meta-analysis
- Edoxaban 12 months superior to 3 months for VTE prevention in cancer DVT, regardless of anemia status
- PALaDIN Study: High vs. Low Dose Iron in Peritoneal Dialysis Patients